STUDY ON RADIOCOLLOIDAL THERAPY YTTRIUM-90 CHLORIDE
Journal Article
·
· Nippon Igaku Hoshasen Gakkai Zasshi (Japan)
OSTI ID:4786263
Radioyttrium chloride was injected into the pleural or peritoneal cavities of patients with far-advanced cancer. The dosage of radioyttrium for intraperitoneal injection was usually 20 to 50 mC at 7- to 10-day intervals. Statistical results have not yet been obtained. However, the malignant cells in the effusions decreased in all cases, and the rate of fluid formation was decreased in 2 cases of bladder cancer, 1 of breast cancer, 1 of cecal tumor, 1 of ovarian tumor, 2 of leukemia, and 1 of carcinomatous pleuritis. In a case of chronic myelogenous leukemia there was improvement of the peripheral blood picture and reduction of the size of the spleen. (Abstr. Japan Med., 2: No. 3, March l962)
- Research Organization:
- Univ. of Tokyo Faculty of Medicine
- NSA Number:
- NSA-16-017421
- OSTI ID:
- 4786263
- Journal Information:
- Nippon Igaku Hoshasen Gakkai Zasshi (Japan), Journal Name: Nippon Igaku Hoshasen Gakkai Zasshi (Japan) Vol. Vol: 20; ISSN NHGZA
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Similar Records
STUDIES ON CLINICAL USE OF COLLOIDAL YTTRIUM-90 (Y$sup 90$)
The Use of Gold and Silver-coated Radioactive Gold Colloids in the Palliation of Ascites and Pleural Effusions
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies
Journal Article
·
Thu Dec 31 23:00:00 EST 1959
· Nippon Igaku Hoshasen Gakkai Zasshi (Japan)
·
OSTI ID:4785359
The Use of Gold and Silver-coated Radioactive Gold Colloids in the Palliation of Ascites and Pleural Effusions
Journal Article
·
Thu May 01 00:00:00 EDT 1958
· British Journal of Radiology
·
OSTI ID:4348107
Intracavitary use of two radiolabeled tumor-associated monoclonal antibodies
Journal Article
·
Wed Nov 30 23:00:00 EST 1988
· J. Nucl. Med.; (United States)
·
OSTI ID:6610814